Skip to main content

P&F Studies

Year: 2024 - 2011
Any text in center title
Any character in name
Any text in pilot study title
2021
Pilot Awardee Center Pilot Study
Priscilla Sato PhD University of Pennsylvania The functional role of GRK2 in regulating islet function
Ismail Sayed PhD Joslin Diabetes Center Effects of novel lipids on on the NLRP3 inflammasome and impact on diabetogenesis in NOD model
Jennifer Schaub MD Orcid University of Michigan A systems biology approach to identify patients with Diabetic Kidney Disease that may benefit from novel prolyl hydroxylase inhibitors
Sejal Shah MD PhD Stanford University Use of Continuous Glucose Monitors in Publicly-Insured Youth with Type 2 Diabetes – A Pilot and Feasibility Study
Eric Stice PhD Orcid Stanford University Evaluating an Eating Disorder Prevention Program for Young Women with Type 1 Diabetes
Yousin Suh PhD Orcid Columbia University Enhancer-based Beta Cell Dysregulation Underlying T2D Risk
Andrew Templin PhD Orcid Indiana University Susceptibility of primary islet beta cells to RIPK3-mediated necroptosis
Kalie Tommerdahl MD Orcid University of Colorado Denver Metformin and Automated Insulin Delivery System Effects on Renal Vascular Resistance and Vascular and Endothelial Function in Youth with Type 1 Diabetes Pilot Study
Linus Tzu-Yen Tsai MD PhD Orcid Joslin Diabetes Center The role of interferon regulatory factors in tanycytes during HFD-induced inflammation, obesity and glucose dysregulation
Luke Wander MD MS Orcid University of Washington Identifying miRNA-Mediated Mechanisms Driving the Protective Effects of Metformin on Beta-Cell Function
I-Chen Yu PhD Orcid Indiana University Deciphering the molecular crosstalk of obesity-related cerebrovascular dysfunction in vascular cognitive impairment and dementia
Daniel Zeve MD, PhD Joslin Diabetes Center Use of human enteroids/organoids to induce K and L enteroendocrine cells that appropriately respond to nutrients in vitro and in vivo.
Li Zhang MD PhD Orcid Indiana University Suppression of antigen-specific monoclonal antibodies in humanized spontaneous Type 1 diabetes mice